Get started
Author

Angela Pepe

Observed name: A. Pepe
Institution: Ospedale San Carlo
ORCID: 0000-0002-5801-0397
Observed ORCID: 0000-0002-5801-0397
OpenAlex ID: A5088751707
Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study
2022 · Vincenzo Carnovale, Paola Iacotucci, et al. · Journal of Clinical Medicine · 60
PDF
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era
2021 · Francesco Valitutti, Alessandra Verde, et al. · Journal of Pediatric Surgery Case Reports · 34
PDF
An Advanced Lens Measurement Approach (ALMA) in post refractive surgery IOL power calculation with unknown preoperative parameters
2020 · Nicola Rosa, Ferdinando Cione, et al. · PLoS ONE · 33
PDF
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis
2023 · Angela Pepe, Angelo Colucci, et al. · Frontiers in Pediatrics · 22
PDF
Drug dosing in children with obesity: a narrative updated review
2022 · Francesca Gaeta, Valeria Conti, et al. · The Italian Journal of Pediatrics/Italian journal of pediatrics · 21
PDF
Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis: A Review of Registry-Based Evidence
2025 · Donatello Salvatore, Angela Pepe · Journal of Clinical Medicine · 20
PDF
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age
2023 · Caterina Mosca, Angelo Colucci, et al. · Nutrients · 18
PDF
Elexacaftor/tezacaftor/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort study
2025 · Angela Pepe, Cristina Fevola, et al. · Therapeutic Advances in Respiratory Disease · 13
Elexacaftor/tezacaftor/ivacaftor in children aged 6–11 years with cystic fibrosis, at least one F508DEL allele, and advanced lung disease: A 24‐week observational study
2022 · Donatello Salvatore, Giuseppe Cimino, et al. · Pediatric Pulmonology · 12
Ivabradine–Flecainide as Breakthrough Drug Combination for Congenital Junctional Ectopic Tachycardia: A Case Report and Literature Review
2021 · Giovanni Maria Di Marco, Angelica De Nigris, et al. · Pediatric Reports · 12
PDF
Corneal thickness evaluation in healthy eyes: Comparison between two different Scheimpflug devices
2020 · Nicola Rosa, Maddalena De Bernardo, et al. · PLoS ONE · 9
PDF
Cystic fibrosis and CFTR-related disorder with electrolyte imbalance at diagnosis: clinical features and outcome in an Italian cohort
2023 · Vito Terlizzi, Rita Padoan, et al. · European Journal of Pediatrics · 7
Real-world effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients with Phe508del -gating and -residual function genotypes
2025 · Donatello Salvatore, Paola Iacotucci, et al. · Respiratory Medicine · 6
The diagnostic and therapeutic challenge of atrial flutter in children: a case report
2023 · Angelica De Nigris, Mattia Arenella, et al. · The Italian Journal of Pediatrics/Italian journal of pediatrics · 5
PDF
Elexacaftor/tezacaftor/ivacaftor for CFTR variants giving rise to diagnostic uncertainty: Personalised medicine or over-medicalisation?
2021 · Donatello Salvatore, Angela Pepe, et al. · Journal of Cystic Fibrosis · 5
Brugada Pattern in a Child with Severe SARS-CoV-2 Related Multisystem Inflammatory Syndrome
2021 · Angelica De Nigris, Angela Pepe, et al. · Pediatric Reports · 5
PDF
Real-World Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis: A 24-Month Italian National Registry Study
2026 · Donatello Salvatore, Giuseppe Campagna, et al. · Journal of Clinical Medicine · 4
PDF
Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children
2023 · Angela Pepe, Claudia Mandato, et al. · Nutrients · 3
PDF
P090 Exploring the adherence to treatment with elexacaftor/tezacaftor/ivacaftor (ETI) In people with cystic fibrosis: a retrospective, dual-center observational study
2025 · A. Pepe, P. Iacotucci, et al. · Journal of Cystic Fibrosis · 1
Letter to the Editor in response to: “ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis”
2025 · Angela Pepe, Claudia Mandato · JPGN Reports · 1
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy
2022 · Angela Pepe, Francesco Valitutti, et al. · The Italian Journal of Pediatrics/Italian journal of pediatrics · 1
PDF
Long-term outcomes of adolescents/adults with CF screen positive, inconclusive diagnosis
2026 · Vito Terlizzi, Angela Pepe, et al. · Journal of Cystic Fibrosis
Author response for "Elexacaftor/tezacaftor/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort study"
2024 · Angela Pepe, Cristina Fevola, et al. · Publons reviews and discussion
Author response for "Elexacaftor/tezacaftor/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort study"
2024 · Angela Pepe, Cristina Fevola, et al. · Publons reviews and discussion
P071 Elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and Phe508del–gating or Phe508del–residual function genotypes: an Italian real-world experience
2024 · A. Pepe, P. Iacotucci, et al. · Journal of Cystic Fibrosis
Works count: 27
Citation count: 292
H-index: 10
I10-index: 10
Year
Topic
Type